To determine the clinical outcomes of patients with gastric cancer (GC), the long noncoding RNA LOC339059, which is associated with the regulation of PD-L1 and its influence on macrophage polarization via the IL-6/STAT3 pathway, can be used as a prognostic marker. This evidence concerns the gene STAT3 and gastric cancer.